PHARMAC responds to Stewart Mann on dihydropyridine calcium channel antagonists.
Davies
Andrew
A
Metcalfe
Scott
S
Moodie
Peter
P
McNee
Wayne
W
D002121:Calcium Channel Blockers / Q000191:economics* / Q000493:pharmacokinetics; D004095:Dihydropyridines / Q000191:economics* / Q000493:pharmacokinetics; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D016568:Drugs, Generic / Q000191:economics; D006801:Humans; D009520:New Zealand; D013810:Therapeutic Equivalency
D002121:Calcium Channel Blockers; D004095:Dihydropyridines; D016568:Drugs, Generic; C038806:1,4-dihydropyridine